The best way to use asparaginase in childhood acute lymphatic leukaemia--still to be defined?
Pinheiro
João Paulo Vieira
JP
Coordination Centre for Clinical Trials (KKS), University Hospital Münster, Münster, Germany.
Boos
Joachim
J
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001215:Asparaginase / Q000627:therapeutic use*; D002648:Child; D004305:Dose-Response Relationship, Drug; D006801:Humans; D011092:Polyethylene Glycols; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D001215:Asparaginase